CB21914-2A - 0x0000000000003A7C

Study Number: CB21914
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: $5,360.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18.5 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat a disorder in which too much growth hormone is produced.
  • Route of Administration: Oral
  • Blood Draws: 43

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 17 Night Stay & 1 Return

Screening Dates:

Event Day Event Date Site
Monday 11/19/2018 Phoenix
Tuesday 11/20/2018 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Monday 11/26/2018 Phoenix
Tuesday 11/27/2018 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 12/2/2018 11:30:00 AM Wednesday 12/19/2018 9:00:00 AM 1 Phoenix
Return Sunday 1/6/2019 7:45:00 AM Sunday 1/6/2019 9:00:00 AM 1 Phoenix